ATYR PHARMA INC's ticker is LIFE and the CUSIP is 002120202. A total of 24 filers reported holding ATYR PHARMA INC in Q1 2020. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2020 | $1,897,000 | -27.3% | 587,444 | 0.0% | 0.01% | -36.4% |
Q2 2020 | $2,608,000 | +58.5% | 587,444 | 0.0% | 0.01% | +22.2% |
Q1 2020 | $1,645,000 | +72.1% | 587,444 | +156.2% | 0.01% | +125.0% |
Q4 2019 | $956,000 | +19.2% | 229,283 | 0.0% | 0.00% | 0.0% |
Q3 2019 | $802,000 | – | 229,283 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Tikvah Management LLC | 1,225,833 | $9,157,000 | 2.55% |
Stonepine Capital Management, LLC | 525,531 | $3,926,000 | 1.80% |
Telemetry Investments, L.L.C. | 176,782 | $1,321,000 | 1.70% |
TANG CAPITAL MANAGEMENT LLC | 1,113,453 | $8,317,000 | 1.67% |
VR Adviser, LLC | 1,565,000 | $11,691,000 | 1.60% |
Deep Track Capital, LP | 1,100,000 | $8,217,000 | 0.58% |
EAM Investors, LLC | 252,280 | $1,885,000 | 0.31% |
EAM Global Investors LLC | 152,792 | $1,141,000 | 0.20% |
FEDERATED HERMES, INC. | 5,222,250 | $39,010,000 | 0.07% |
Alyeska Investment Group, L.P. | 674,975 | $5,042,000 | 0.06% |